| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 3e-09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.82 | 0.0007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |